Basal cell carcinoma of skin of nose
ICD-10 C44.311 is a billable code used to indicate a diagnosis of basal cell carcinoma of skin of nose.
Basal cell carcinoma (BCC) is the most common form of skin cancer, primarily arising from the basal cells in the epidermis. This type of cancer is typically associated with prolonged sun exposure, making it prevalent in individuals with fair skin, a history of sunburns, or those who frequently engage in outdoor activities without adequate sun protection. BCC of the skin of the nose is particularly concerning due to the cosmetic and functional implications of the tumor's location. Clinically, BCC may present as a pearly or waxy bump, a flat, flesh-colored lesion, or a scar-like area. Surgical excision is the primary treatment modality, with the goal of achieving clear surgical margins to minimize recurrence. Reconstruction may be necessary depending on the size and depth of the excised lesion, especially in cosmetically sensitive areas like the nose. The prognosis for BCC is generally favorable, but careful monitoring and follow-up are essential to detect any new lesions or recurrences.
Detailed descriptions of the lesion, including size, location, and histological findings.
Diagnosis and treatment of BCC, Mohs micrographic surgery, and post-operative care.
Ensure accurate coding of any reconstruction procedures performed after excision.
Comprehensive notes on reconstructive techniques used and the rationale for surgical decisions.
Reconstruction following excision of BCC, especially on the nose.
Document the extent of tissue loss and the method of reconstruction to support coding.
Used for excision of BCC on the nose with reconstruction.
Document the size of the lesion and the surgical margins.
Dermatology and plastic surgery may collaborate on these cases.
The primary treatment for basal cell carcinoma is surgical excision, often using Mohs micrographic surgery for lesions in cosmetically sensitive areas like the nose.
